Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4A11 | Q02928 | 5/20 | 0.46 |
| ▸ | CYP4F2 | P78329 | 4/20 | 0.46 |
| ▸ | PPARA | Q07869 | 1/20 | 0.41 |
| ▸ | CYP4Z1 | Q86W10 | 2/20 | 0.39 |
| ▸ | CYP4F11 | Q9HBI6 | 1/20 | 0.39 |
| ▸ | CYP4F12 | Q9HCS2 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | LTA4H | P09960 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6406595 | 0.96 | CYP4A11 (0.47) | CYP4A11CYP4F2PPARACYP4Z1CYP4F11 | |
| SCHEMBL6405545 | 0.88 | CYP4Z1 (0.41) | CYP4A11CYP4F2CYP4Z1CYP4F11CYP4F12 | |
| SCHEMBL6554455 | 0.87 | THRA (0.43) | CYP4A11CYP4F2CYP4Z1CYP4F11CYP4F12 | |
| SCHEMBL6554503 | 0.78 | CYP4A11 (0.45) | CYP4A11CYP4F2PPARACA2ALOX5 | |
| SCHEMBL9869627 | 0.76 | ALDH1A1 (0.50) | CTDSP1LMNAALDH1A1HPGDHSD17B10 | |
| SCHEMBL8866817 | 0.74 | CYP4F2 (0.57) | CYP4A11CYP4F2PPARACA2CTDSP1 | |
| SCHEMBL3049924 | 0.73 | CYP4A11 (0.70) | CYP4A11CYP4F2CA2LMNAALDH1A1 | |
| SCHEMBL5755875 | 0.72 | HPGD (0.44) | CA2ALDH1A1HPGDHSD17B10 | |
| SCHEMBL9495382 | 0.71 | IGF1R (0.46) | CYP4A11CYP4F2PPARACA2LTA4H | |
| SCHEMBL26295423 | 0.71 | IGF1R (0.46) | CYP4A11CYP4F2PPARACA2LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050171101-A1 | Phenanthridinones as parp inhibitors | FUJISAWA PHARMACEUTICAL CO. LTD. (JP) | 2005-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050171101-A1 | Phenanthridinones as parp inhibitors | PARP1, PARP11, PARP2 | CYP4A11 2762/4885CYP4F2 3749/4885PPARA 3832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.